CLINICAL_TRIALS
trial_result
· 2015-11-30
Clinical Trial Update: Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus [Phase 2]
Summary
A Phase 2 trial evaluating the combination of daclatasvir and simeprevir in genotype 1 chronic hepatitis C infection; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2015-11-30